Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects

Clinical trial NCT01897779 · COMPLETED

Trial details

NCT number: NCT01897779
Sponsor: Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Bacterial Infections

Start date: 2013-07-01
Primary completion: 2014-02-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.